Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart AssociationCIRCULATIONIF38.62016-12-06333OAAI
Bariatric Surgery in Patients With Left Ventricular Systolic Dysfunction Effective, But Is It Safe?jacc heart failureIF8.42016-03-018OAAI
Worsening renal function is not associated with response to treatment in acute heart failureINTERNATIONAL JOURNAL OF CARDIOLOGYIF3.22013-09-0122OAAI
Segmental Analysis of Carotid Arterial Strain Using Speckle-TrackingJOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHYIF62011-11-0131OAAI
Lack of Association of Changes in BNP with Cardiorenal Syndrome during Treatment of Acute Decompensated Heart FailureJOURNAL OF CARDIAC FAILUREIF8.22011-08-010PREAI
Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction: A complex relationshipAMERICAN HEART JOURNALIF3.52011-03-0161OAAI
Loss after Initial Gain in LVEF With β-Blocker Therapy in Heart Failure PatientsJOURNAL OF CARDIAC FAILUREIF8.22010-08-010OA
Reduction in BNP Levels With Treatment of Decompensated Heart Failure and Future Clinical EventsJOURNAL OF CARDIAC FAILUREIF8.22009-05-0146PREAI
The metabolic syndrome and mortality in an ethnically diverse heart failure populationJOURNAL OF CARDIAC FAILUREIF8.22008-09-0113PRE
Thiazolidinediones are not associated with increased risk of heart failure hospitalizations in ambulatory patients with diabetes mellitus and heart failureJOURNAL OF CARDIAC FAILUREIF8.22006-08-010PRE